NEW
Stock Screener with Intrinsic Value
Vertex Pharmaceuticals Incorporated (VRTX)
Last Price$409.9(0.5%)
Market Cap$105.0B
$10.6B
+9.9% YoY
($479.8M)
N/A
($4,821.6M)
Net Debt to FCF - 4.1x
($1,163.8M)
(11.0% margin)
VRTX Income Statement
VRTX Income Statement Overview
Crunching data... Almost there!
VRTX Income statement key metrics
Crunching data... Almost there!
VRTX Balance Sheet
VRTX Balance Sheet Overview
Crunching data... Almost there!
VRTX Balance Sheet Metrics
Crunching data... Almost there!
VRTX Cash Flow Statement
VRTX Cash Flow Statement Overview
Crunching data... Almost there!
VRTX Cash Flow Statement key metrics
Crunching data... Almost there!
VRTX Financials
Crunching data... Almost there!
FAQ
What is the Vertex Pharmaceuticals Incorporated (VRTX) revenue?
The Vertex Pharmaceuticals Incorporated (VRTX) revenue is $9,869.2M, reflecting a year-over-year (YoY) growth of +10.5% YoY.
What is the Vertex Pharmaceuticals Incorporated (VRTX) Net Income?
The Vertex Pharmaceuticals Incorporated (VRTX) Net Income is $3,619.6M, showcasing a YoY growth of +9.0% YoY.